Marshall MS - Search Results

1

Pancreatic tumor cells with mutant K-ras suppress ERK activity by MEK-dependent induction of MAP kinase phosphatase-2.

Yip-Schneider MT, Lin A, Marshall MS. Yip-Schneider MT, et al. Among authors: marshall ms. Biochem Biophys Res Commun. 2001 Feb 2;280(4):992-7. doi: 10.1006/bbrc.2001.4243. Biochem Biophys Res Commun. 2001. PMID: 11162624

2

Lack of elevated MAP kinase (Erk) activity in pancreatic carcinomas despite oncogenic K-ras expression.

Yip-Schneider MT, Lin A, Barnard D, Sweeney CJ, Marshall MS. Yip-Schneider MT, et al. Among authors: marshall ms. Int J Oncol. 1999 Aug;15(2):271-9. doi: 10.3892/ijo.15.2.271. Int J Oncol. 1999. PMID: 10402237

3

Cyclooxygenase-2 expression in human pancreatic adenocarcinomas.

Yip-Schneider MT, Barnard DS, Billings SD, Cheng L, Heilman DK, Lin A, Marshall SJ, Crowell PL, Marshall MS, Sweeney CJ. Yip-Schneider MT, et al. Among authors: marshall ms, marshall sj. Carcinogenesis. 2000 Feb;21(2):139-46. doi: 10.1093/carcin/21.2.139. Carcinogenesis. 2000. PMID: 10657949

4

Regulation of the Raf-1 kinase domain by phosphorylation and 14-3-3 association.

Yip-Schneider MT, Miao W, Lin A, Barnard DS, Tzivion G, Marshall MS. Yip-Schneider MT, et al. Among authors: marshall ms. Biochem J. 2000 Oct 1;351(Pt 1):151-9. doi: 10.1042/0264-6021:3510151. Biochem J. 2000. PMID: 10998357 Free PMC article.

5

Parthenolide and sulindac cooperate to mediate growth suppression and inhibit the nuclear factor-kappa B pathway in pancreatic carcinoma cells.

Yip-Schneider MT, Nakshatri H, Sweeney CJ, Marshall MS, Wiebke EA, Schmidt CM. Yip-Schneider MT, et al. Among authors: marshall ms. Mol Cancer Ther. 2005 Apr;4(4):587-94. doi: 10.1158/1535-7163.MCT-04-0215. Mol Cancer Ther. 2005. PMID: 15827332

6

Cell cycle effects of nonsteroidal anti-inflammatory drugs and enhanced growth inhibition in combination with gemcitabine in pancreatic carcinoma cells.

Yip-Schneider MT, Sweeney CJ, Jung SH, Crowell PL, Marshall MS. Yip-Schneider MT, et al. Among authors: marshall ms. J Pharmacol Exp Ther. 2001 Sep;298(3):976-85. J Pharmacol Exp Ther. 2001. PMID: 11504793

7

Cyclo-oxygenase-2 expression in primary cancers of the lung and bladder compared to normal adjacent tissue.

Sweeney CJ, Marshall MS, Barnard DS, Heilman DK, Billings SD, Cheng L, Marshall SJ, Yip-Schneider MT. Sweeney CJ, et al. Among authors: marshall ms, marshall sj. Cancer Detect Prev. 2002;26(3):238-44. doi: 10.1016/s0361-090x(02)00064-8. Cancer Detect Prev. 2002. PMID: 12269772

8

In vitro inhibition of Ras-Raf association by short peptides.

Barnard D, Sun H, Baker L, Marshall MS. Barnard D, et al. Among authors: marshall ms. Biochem Biophys Res Commun. 1998 Jun 9;247(1):176-80. doi: 10.1006/bbrc.1998.8746. Biochem Biophys Res Commun. 1998. PMID: 9636675

9

Molecular mechanism for the Shp-2 tyrosine phosphatase function in promoting growth factor stimulation of Erk activity.

Shi ZQ, Yu DH, Park M, Marshall M, Feng GS. Shi ZQ, et al. Mol Cell Biol. 2000 Mar;20(5):1526-36. doi: 10.1128/MCB.20.5.1526-1536.2000. Mol Cell Biol. 2000. PMID: 10669730 Free PMC article.

10

Insulin signaling inhibits the 5-HT2C receptor in choroid plexus via MAP kinase.

Hurley JH, Zhang S, Bye LS, Marshall MS, DePaoli-Roach AA, Guan K, Fox AP, Yu L. Hurley JH, et al. Among authors: marshall ms. BMC Neurosci. 2003 Jun 9;4:10. doi: 10.1186/1471-2202-4-10. BMC Neurosci. 2003. PMID: 12795815 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

195 results

Search Page

Filters